The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
The cytokine storm of severe influenza and development of immunomodulatory therapy
Open accessAbstract
Severe influenza remains unusual in its virulence for humans. Complications or ultimately death arising from these infections are often associated with hyperinduction of proinflammatory cytokine production, which is also known as ‘cytokine storm’. For this disease, it has been proposed that immunomodulatory therapy may improve the outcome, with or without the combination of antiviral agents. Here, we review the current literature on how various effectors of the immune system initiate the cytokine storm and exacerbate pathological damage in hosts. We also review some of the current immunomodulatory strategies for the treatment of cytokine storms in severe influenza, including corticosteroids, peroxisome proliferator-activated receptor agonists, sphingosine-1-phosphate receptor 1 agonists, cyclooxygenase-2 inhibitors, antioxidants, anti-tumour-necrosis factor therapy, intravenous immunoglobulin therapy, statins, arbidol, herbs, and other potential therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858
1918 Influenza: the Mother of All Pandemics
Taubenberger, J. K., & Morens, D. M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.050979 · Cited by 1,686
1918 Influenza: the Mother of All Pandemics
Taubenberger, J. K., & Morens, D. M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1209.05-0979 · Cited by 1,590
Avian Influenza A (H5N1) Infection in Humans
(2005) · New England Journal of Medicine · doi:10.1056/nejmra052211 · Cited by 1,285
Gao, H., Yang, Z., Zhang, S., Cao, S., Shen, S., Pang, Z., & Jiang, X. (2014) · Scientific Reports · doi:10.1038/srep05138 · Cited by 1,061
Self-citationTeijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., Martinborough, E., Peach, R., Oldstone, M. B. A., & Rosen, H. (2011) · Cell · doi:10.1016/j.cell.2011.08.015 · Cited by 688
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
Gao, H.-N., Lu, H.-Z., Cao, B., Du, B., Shang, H., Gan, J.-H., Lu, S.-H., Yang, Y.-D., Fang, Q., Shen, Y.-Z., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305584 · Cited by 651
Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?
Luke, T. C., Kilbane, E. M., Jackson, J. L., & Hoffman, S. L. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00139 · Cited by 636
A calculated response: control of inflammation by the innate immune system
Barton, G. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34431 · Cited by 532
Arbidol as a broad-spectrum antiviral: An update
Blaising, J., Polyak, S. J., & Pécheur, E.-I. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.04.006 · Cited by 485
A question of self‐preservation: immunopathology in influenza virus infection
La Gruta, N. L., Kedzierska, K., Stambas, J., & Doherty, P. C. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb.7100026 · Cited by 459
Dawson, T. C., Beck, M. A., Kuziel, W. A., Henderson, F., & Maeda, N. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65068-7 · Cited by 379
Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice
Szretter, K. J., Gangappa, S., Lu, X., Smith, C., Shieh, W.-J., Zaki, S. R., Sambhara, S., Tumpey, T. M., & Katz, J. M. (2007) · Journal of Virology · doi:10.1128/jvi.02336-06 · Cited by 374
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
Bermejo-Martin, J. F., Ortiz de Lejarazu, R., Pumarola, T., Rello, J., Almansa, R., Ramírez, P., Martin-Loeches, I., Varillas, D., Gallegos, M. C., Serón, C., et al. (2009) · Critical Care · doi:10.1186/cc8208 · Cited by 373
Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome
Brun-Buisson, C., Richard, J.-C. M., Mercat, A., Thiébaut, A. C. M., & Brochard, L. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0135oc · Cited by 338
Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia
Kurahashi, K., Kajikawa, O., Sawa, T., Ohara, M., Gropper, M. A., Frank, D. W., Martin, T. R., & Wiener-Kronish, J. P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7124 · Cited by 316
Zheng, B.-J., Chan, K.-W., Lin, Y.-P., Zhao, G.-Y., Chan, C., Zhang, H.-J., Chen, H.-L., Wong, S. S. Y., Lau, S. K. P., Woo, P. C. Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711942105 · Cited by 302
Zarogoulidis, P., Papanas, N., Kioumis, I., Chatzaki, E., Maltezos, E., & Zarogoulidis, K. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1161-x · Cited by 299
Hyperimmune IV Immunoglobulin Treatment
Hung, I. F. N., To, K. K. W., Lee, C.-K., Lee, K.-L., Yan, W.-W., Chan, K., Chan, W.-M., Ngai, C.-W., Law, K.-I., Chow, F.-L., et al. (2013) · Chest · doi:10.1378/chest.12-2907 · Cited by 286
Chong, P. Y., Chui, P., Ling, A. E., Franks, T. J., Tai, D. Y. H., Leo, Y. S., Kaw, G. J. L., Wansaicheong, G., Chan, K. P., Ean Oon, L. L., et al. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-195-aoddts · Cited by 270
Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection
Salomon, R., Hoffmann, E., & Webster, R. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705289104 · Cited by 265
Inhibition of Influenza A Virus Replication by Resveratrol
Palamara, A. T., Nencioni, L., Aquilano, K., De Chiara, G., Hernandez, L., Cozzolino, F., Ciriolo, M. R., & Garaci, E. (2005) · The Journal of Infectious Diseases · doi:10.1086/429694 · Cited by 254
Innate immune responses to influenza A H5N1: friend or foe?
Peiris, J. S. M., Cheung, C. Y., Leung, C. Y. H., & Nicholls, J. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.09.004 · Cited by 232
Geiler, J., Michaelis, M., Naczk, P., Leutz, A., Langer, K., Doerr, H.-W., & Cinatl, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.025 · Cited by 205
Michaelis, M., Geiler, J., Naczk, P., Sithisarn, P., Leutz, A., Doerr, H. W., & Cinatl, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019705 · Cited by 164
Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells
Kesic, M. J., Simmons, S. O., Bauer, R., & Jaspers, I. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.027 · Cited by 164
Host response to influenza virus: protection versus immunopathology
Peiris, J., Hui, K. P., & Yen, H.-L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.003 · Cited by 160
Treating influenza with statins and other immunomodulatory agents
Fedson, D. S. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.06.018 · Cited by 159
Mortensen, E. M., Nakashima, B., Cornell, J., Copeland, L. A., Pugh, M. J., Anzueto, A., Good, C., Restrepo, M. I., Downs, J. R., Frei, C. R., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis733 · Cited by 158
Brincks, E. L., Roberts, A. D., Cookenham, T. S., Sell, S., Kohlmeier, J. E., Blackman, M. A., & Woodland, D. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203140 · Cited by 152
Cilloniz, C., Pantin-Jackwood, M. J., Ni, C., Goodman, A. G., Peng, X., Proll, S. C., Carter, V. S., Rosenzweig, E. R., Szretter, K. J., Katz, J. M., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00553-10 · Cited by 136
Immunomodulatory therapy for severe influenza
Darwish, I., Mubareka, S., & Liles, W. C. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.56 · Cited by 136
Ichiyama, T., Isumi, H., Ozawa, H., Matsubara, T., Morishima, T., & Furukawa, S. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/0036554021000026986 · Cited by 116
Aspects on antibacterial treatment of anaerobic infections.
Nordbring, F., & Nord, C. E. (1982) · PubMed · Cited by 114
A Critical Role for OX40 in T Cell–mediated Immunopathology during Lung Viral Infection
Humphreys, I. R., Walzl, G., Edwards, L., Rae, A. J., Hill, S., & Hussell, T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030351 · Cited by 106
Increased Survival after Gemfibrozil Treatment of Severe Mouse Influenza
Budd, A. C., Alleva, L. M., Alsharifi, M., Koskinen, A. M. L., Smythe, V., Müllbacher, A., Wood, J. T., & Clark, I. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00219-07 · Cited by 102
Shinya, K., Gao, Y., Cillóniz, C., Suzuki, Y., Fujie, M., Deng, G., Zhu, Q., Fan, S., Makino, A., Muramoto, Y., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00365-12 · Cited by 97
Lin, K. L., Sweeney, S., Kang, B. D., Ramsburg, E. A., & Gunn, M. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001002 · Cited by 94
Poon, P. M. K., Wong, C. K., Fung, K., Fong, C., Wong, E. L., Lau, J. T. F., Leung, P. C. K., Tsui, S. K., Wan, D. C., Waye, M. M. Y., et al. (2006) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x0600359x · Cited by 92
PPAR-γ Activation As an Anti-inflammatory Therapy for Respiratory Virus Infections
Bassaganya-Riera, J., Song, R., Roberts, P. C., & Hontecillas, R. (2010) · Viral Immunology · doi:10.1089/vim.2010.0016 · Cited by 83
N-Acetylcysteine Synergizes with Oseltamivir in Protecting Mice from Lethal Influenza Infection
Garozzo, A., Tempera, G., UNGHERI, D., Timpanaro, R., & Castro, A. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000215 · Cited by 78
Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice
Carey, M. A., Bradbury, J. A., Rebolloso, Y. D., Graves, J. P., Zeldin, D. C., & Germolec, D. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011610 · Cited by 77
Moseley, C. E., Webster, R. G., & Aldridge, J. R. (2010) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2010.00155.x · Cited by 77
Kedzierski, Ł., Linossi, E. M., Kolesnik, T. B., Clemens, E. B., Bird, N. L., Kile, B. T., Belz, G. T., Metcalf, D., Nicola, N. A., Kedzierska, K., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004134 · Cited by 76
Liu, Q., Xiong, H., Lü, L., Liu, Y.-Y., Luo, F., Hou, W., & Zhan-qiu, Y. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.54 · Cited by 75
Self-citationLing, J., Wei, F., Li, N., Li, J., Chen, L., Liu, Y.-Y., Luo, F., Xiong, H., Hou, W., & Yang, Z. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.80 · Cited by 72
Self-citationEffect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice
Xu, T., Qiao, J., Zhao, L., He, G., Li, K., Wang, J., Tian, Y., & Wang, H.-F. (2009) · European Respiratory Journal · doi:10.1183/09031936.00130507 · Cited by 71
Viasus, D., Paño‐Pardo, J. R., Cordero, E., Campins, A. A., López‐Medrano, F., Villoslada, A., Fariñas, M. C., Moreno, A., Rodríguez‐Baño, J., Oteo, J. A., et al. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.01.014 · Cited by 69
Liu, Q., Liu, D., & Yang, Z. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.121 · Cited by 65
Self-citationCharacterizing and controlling the inflammatory network during influenza A virus infection
Jin, S., Li, Y., Pan, R., & Zou, X. (2014) · Scientific Reports · doi:10.1038/srep03799 · Cited by 64
Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection
Oldstone, M. B. A., Teijaro, J. R., Walsh, K. B., & Rosen, H. (2012) · Virology · doi:10.1016/j.virol.2012.09.039 · Cited by 57
Muramoto, Y., Shoemaker, J. E., Le, M. Q., Itoh, Y., Tamura, D., Sakai‐Tagawa, Y., Imai, H., Uraki, R., Takano, R., Kawakami, E., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00907-14 · Cited by 54
Structured regulation of inflammation during respiratory viral infection
Hussell, T., & Goulding, J. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70067-0 · Cited by 53
Liu, Z., Guo, Z., Wang, G., Zhang, D., He, H., Li, G., Liu, Y., Higgins, D., Walsh, A., Shanahan-Prendergast, L., et al. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.004 · Cited by 52
Drugs to cure avian influenza infection – multiple ways to prevent cell death
Yuan, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.367 · Cited by 48
Kudo, K., Takasaki, J., Manabe, T., Uryu, H., Yamada, R., Kuroda, E., Kobayashi, N., & Matsushita, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032280 · Cited by 47
Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza
Alleva, L. M., Cai, C., & Clark, I. A. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep152 · Cited by 35
Yao, M., Yao, D., Yamaguchi, M., Chida, J., Yao, D., & Kido, H. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.07.009 · Cited by 30
Clinical characteristics of human infection with a novel avian-origin influenza A(H10N8) virus
Zhang, W., Jianguo, W., Kejian, Q., Xiaoqing, L., Zuke, X., Jian, S., Zeng, Z., Wang, Q. M., Jinxiang, Z., Guanghui, J., et al. (2014) · Chinese Medical Journal · doi:10.1097/00029330-201409200-00009 · Cited by 29
Genetic Insights into Sepsis: What have we Learned and How will it Help?
Wurfel, M. M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784980554 · Cited by 29
Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury
Ramana, C. V., Cheng, G., Kumar, A., Kwon, H., & Enelow, R. I. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.09.001 · Cited by 21
Cited by
Karki, R., Sharma, B. R., Tuladhar, S., Williams, E. P., Zalduondo, L., Samir, P., Zheng, M., Sundaram, B., Banoth, B., Malireddi, R. K. S., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.025 · Cited by 1,734
The cytokine storm and COVID-19
Hu, B., Huang, S., & Yin, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26232 · Cited by 1,655
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Azkur, A. K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M., O’Mahony, L., Gao, Y., Nadeau, K., & Akdis, C. A. (2020) · Allergy · doi:10.1111/all.14364 · Cited by 1,119
Lin, L., Lu, L., Cao, W., & Li, T. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1746199 · Cited by 914
Liu, B., Li, M., Zhou, Z., Guan, X., & Xiang, Y. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102452 · Cited by 763
Metadata
- Authors
- Liu, Q., Zhou, Y.-H., & Yang, Z.-Q.
- Venue
- Cellular & Molecular Immunology
- Published
- 2015-07-20
- Volume
- 13
- Issue
- 1
- Pages
- 3-10
- ISSN
- 1672-7681 (ISSN-L)
- 2042-0226
- OpenAlex
- W1586165122
- Cited by
- 716
- References
- 63
- FWCI
- 17.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.